Walleye Trading

Walleye Trading’s BridgeBio Pharma BBIO Stock Holding History

Walleye Trading’s Portfolio BBIO Stock Details BBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$130K	Sell	1,745 -2,386	-58%	-$173K	﹤0.01%	3336
2025 Q4	$316K	Buy	4,131 +1,011	+32%	+$66.4K	0.01%	3120
2025 Q3	$162K	Sell	3,120 -912	-23%	-$44.5K	﹤0.01%	3473
2025 Q2	$174K	Buy	4,032 +3,798	+1,623%	+$138K	﹤0.01%	3320
2025 Q1	$8.09K	Sell	234 -9,128	-98%	-$308K	﹤0.01%	3863
2024 Q4	$257K	Buy	+9,362	New	+$242K	0.01%	3099
2024 Q3	–	Hold	0	–	–	–	4161
2024 Q2	–	Hold	0	–	–	–	4331
2024 Q1	–	Hold	0	–	–	–	4798
2023 Q4	–	Hold	0	–	–	–	5110
2023 Q3	–	Sell	-28,413	Closed	-$806K	–	5058
2023 Q2	$489K	Buy	+28,413	New	+$428K	0.03%	2766
2023 Q1	–	Hold	0	–	–	–	4925
2022 Q3	–	Sell	-26,896	Closed	-$244K	–	5094
2022 Q2	$244K	Buy	26,896 +13,395	+99%	+$112K	0.01%	3541
2022 Q1	$137K	Buy	+13,501	New	+$139K	﹤0.01%	4075
2021 Q3	–	Sell	-94	Closed	-$6K	–	5281
2021 Q2	$6K	Sell	94 -1,248	-93%	-$71.3K	﹤0.01%	4989
2021 Q1	$83K	Buy	+1,342	New	+$87.8K	﹤0.01%	4172

Other funds holding BBIO

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

Janus Henderson Group

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Viking Global Investors

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return